Immunomodulatory potential of anti-idiotypic antibodies for the treatment of autoimmune diseases.

Abstract

The immune system is a complex network of specialized cells and organs that recognises and reacts against foreign pathogens while remaining unresponsive to host tissues. This ability to self-tolerate is known as immunological tolerance. Autoimmune disease occurs when the immune system fails to differentiate between self and non-self antigens and releases autoantibodies to attack our own cells. Anti-idiotypic (anti-ID) antibodies are important in maintaining a balanced idiotypic regulatory network by neutralising and inhibiting the secretion of autoantibodies. Recently, anti-ID antibodies have been advanced as an alternative form of immunotherapy as they can specifically target autoantibodies, cause less toxicity and side effects, and could provide long-lasting immunity. This review article discusses the immunomodulatory potential of anti-ID antibodies for the treatment of autoimmune diseases.

• Authors: Shing Yi Pan, Yvonne Cashinn Chia, Hui Rong Yee, Angelina Ying Fang Cheng, Clarice Evey Anjum, Yenny Kenisi, Mike Ks Chan, Michelle Bf Wong
• Journal: Future science OA (Future Sci OA) Vol. 7 Issue 2 Pg. FSO648 (Oct 29 2020) ISSN: 2056-5623 [Print] England
• PMID: 33437514 (Publication Type: Journal Article, Review)
• Copyright: © 2020 Shing Yi Pan, Yvonne Cashinn Chia, Hui Rong Yee et al.